Press Releases2020-06-26T11:08:11+00:00


2911, 2019

Professor Anders Fasth joins the scientific advisory board

November 29th, 2019|

Press release November 29, 2019 Lipum has developed a biological drug candidate for treatment of chronic inflammatory diseases and aim for a better treatment of juvenile idiopathic arthritis (JIA), that affects children. Therefore, the scientific [...]

1903, 2019

Lipum and Abzena sign integrated CMC agreement

March 19th, 2019|

Press release march 19 2019 Abzena, the global biologics gene to GMP partner research organization, announced it has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic [...]

603, 2019

Umeåföretag tar nästa steg mot ett nytt läkemedel

March 6th, 2019|

Pressrelease 3 juni, 2019 Ladda ned pressrelase: Investerare satsar 25 MSEK på nytt läkemedel (pdf) » Umeåföretaget Lipum utvecklar ett biologiskt läkemedel för behandling av kroniska inflammationer. Tidigare pre-kliniska studier har visat mycket goda resultat [...]

2908, 2018

Lipum receives 2.2 M€ grant from Horizon 2020

August 29th, 2018|

Press release Aug 29, 2018 Lipum's unique approach for treatment of chronic inflammatory diseases receives 2.2 M€ support from EU Horizon 2020, the EU framework program for research and development, will grant 2.2 million euros [...]